StockData
Ocular Therapeutix, Inc logo

Ocular Therapeutix, Inc (OCUL) stock

OCULNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 3/3011% above fair value
$6.02+0.01 (+0.17%)

Close on Nov 17, 2026Market cap $1.32BP/E –Yield –

Ocular Therapeutix profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Ocular Therapeutix's profit margin for the twelve months ending Jun 30, 2026 was -579.1%. For fiscal 2025 it was -511.9%, against -303.7% the year before. The highest annual figure on record is -15.1% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-511.9%−208.2
FY2024Dec 31, 2024-303.7%−165.5
FY2023Dec 31, 2023-138.1%−0.2
FY2022Dec 31, 2022-138.0%−122.9
FY2021Dec 31, 2021-15.1%+879.2
FY2020Dec 31, 2020-894.3%+1149.0
FY2019Dec 31, 2019-2043.3%+970.6
FY2018Dec 31, 2018-3014.0%+282.2
FY2017Dec 31, 2017-3296.2%−927.2
FY2016Dec 31, 2016-2369.0%−97.7
FY2015Dec 31, 2015-2271.3%+1439.6
FY2014Dec 31, 2014-3710.9%+137219.1
FY2012Dec 31, 2012-140930.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-584.5%−80.7
Q1 FY2026Mar 31, 2026-821.6%−222.9
Q4 FY2025Dec 31, 2025-488.0%−204.7
Q3 FY2025Sep 30, 2025-477.3%−240.7
Q2 FY2025Jun 30, 2025-503.9%−237.6
Q1 FY2025Mar 31, 2025-598.7%−159.8
Q4 FY2024Dec 31, 2024-283.3%−85.8
Q3 FY2024Sep 30, 2024-236.6%−233.2
Q2 FY2024Jun 30, 2024-266.3%−130.1
Q1 FY2024Mar 31, 2024-438.9%−212.2
Q4 FY2023Dec 31, 2023-197.4%−87.0
Q3 FY2023Sep 30, 2023-3.4%+198.7
Q2 FY2023Jun 30, 2023-136.2%+16.8
Q1 FY2023Mar 31, 2023-226.7%−131.6
Q4 FY2022Dec 31, 2022-110.4%−79.1
Q3 FY2022Sep 30, 2022-202.2%−224.0
Q2 FY2022Jun 30, 2022-153.0%−80.6
Q1 FY2022Mar 31, 2022-95.1%−137.6
Q4 FY2021Dec 31, 2021-31.3%+1133.7
Q3 FY2021Sep 30, 202121.9%+225.1
Q2 FY2021Jun 30, 2021-72.4%+2258.3
Q1 FY2021Mar 31, 202142.5%+867.0
Q4 FY2020Dec 31, 2020-1164.9%−11.7
Q3 FY2020Sep 30, 2020-203.3%+2061.9
Q2 FY2020Jun 30, 2020-2330.7%+1431.3
Q1 FY2020Mar 31, 2020-824.5%+2656.0
Q4 FY2019Dec 31, 2019-1153.2%+2298.9
Q3 FY2019Sep 30, 2019-2265.1%+748.9
Q2 FY2019Jun 30, 2019-3762.0%−1631.8
Q1 FY2019Mar 31, 2019-3480.5%+568.0
Q4 FY2018Dec 31, 2018-3452.2%−761.8
Q3 FY2018Sep 30, 2018-3014.1%−37.6
Q2 FY2018Jun 30, 2018-2130.2%+2137.8
Q1 FY2018Mar 31, 2018-4048.5%−675.3
Q4 FY2017Dec 31, 2017-2690.3%−181.2
Q3 FY2017Sep 30, 2017-2976.5%−964.7
Q2 FY2017Jun 30, 2017-4268.0%–
Q1 FY2017Mar 31, 2017-3373.3%–
Q4 FY2016Dec 31, 2016-2509.2%–
Q3 FY2016Sep 30, 2016-2011.7%–

More Ocular Therapeutix figures

See a number that looks wrong?